Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of $0.61, $0.78 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $1.39 million versus the consensus estimate of $2.3 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.